| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Abnormality of the urethra | HSPG2 MYH3 CCDC22 BICRA USP9X POLE ARID1A ITGB4 POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 LTBP1 | 9.60e-07 | 465 | 45 | 16 | HP:0000795 |
| HumanPheno | Hypospadias | HSPG2 MYH3 CCDC22 BICRA USP9X POLE ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 | 2.33e-06 | 377 | 45 | 14 | HP:0000047 |
| HumanPheno | Displacement of the urethral meatus | HSPG2 MYH3 CCDC22 BICRA USP9X POLE ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 | 4.31e-06 | 397 | 45 | 14 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | HSPG2 MYH3 CCDC22 BICRA USP9X POLE ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 | 4.57e-06 | 399 | 45 | 14 | HP:0032076 |
| HumanPheno | Depressed nasal bridge | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 POLRMT U2AF2 ARID1A POLR3A EPG5 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 | 7.77e-06 | 612 | 45 | 17 | HP:0005280 |
| HumanPheno | Flattened nasal bridge | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 POLRMT U2AF2 ARID1A POLR3A EPG5 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 | 7.77e-06 | 612 | 45 | 17 | HP:0000425 |
| HumanPheno | Abnormality of the lower urinary tract | HSPG2 MYH3 CCDC22 BICRA USP9X POLE POLRMT ARID1A ITGB4 POLR3A EPG5 KY DACT1 VAC14 KMT2D GPC3 SACS WASHC5 LTBP1 EIF2AK1 TNXB | 1.23e-05 | 937 | 45 | 21 | HP:0010936 |
| HumanPheno | Joint contractures | HSPG2 MYH3 CCDC22 NUP88 UPF3B POLR3A KY TGM1 RAB3GAP1 GPC3 DNA2 | 3.20e-05 | 292 | 45 | 11 | HP:0001372 |
| HumanPheno | Abnormal brain-evoked potentials | MYH3 CCDC22 USP9X NUP88 ARID1A POLR3A RAB3GAP1 GPC3 SACS WASHC5 | 4.10e-05 | 246 | 45 | 10 | HP:0430106 |
| HumanPheno | Cerebellar malformation | CCDC22 BICRA USP9X NUP88 ARID1A POLR3A EPG5 DACT1 RAB3GAP1 KMT2D GPC3 SACS WASHC5 DYNC1H1 | 4.53e-05 | 487 | 45 | 14 | HP:0002438 |
| HumanPheno | Type 2 muscle fiber predominance | 5.22e-05 | 9 | 45 | 3 | HP:0010602 | |
| HumanPheno | Shoulder flexion contracture | 5.22e-05 | 9 | 45 | 3 | HP:0003044 | |
| HumanPheno | Abnormal penis morphology | HSPG2 MYH3 CCDC22 BICRA USP9X POLE ARID1A POLR3A EPG5 TFR2 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 SACS WASHC5 | 5.86e-05 | 712 | 45 | 17 | HP:0000036 |
| HumanPheno | Complex cardiac malformations | HSPG2 CCDC22 BICRA ARID1A DACT1 VAC14 KMT2D GPC3 WASHC5 HYDIN | 5.97e-05 | 257 | 45 | 10 | HP:0002565 |
| HumanPheno | Hydronephrosis | HSPG2 CCDC22 USP9X POLE ITGB4 POLR3A RAB3GAP1 KMT2D GPC3 WASHC5 | 7.49e-05 | 264 | 45 | 10 | HP:0000126 |
| HumanPheno | Shoulder contracture | 1.01e-04 | 11 | 45 | 3 | HP:0034665 | |
| HumanPheno | Aplasia/Hypoplasia of the nipples | 1.17e-04 | 56 | 45 | 5 | HP:0006709 | |
| HumanPheno | Abnormal ventriculoarterial connection | HSPG2 CCDC22 BICRA ARID1A DACT1 VAC14 KMT2D GPC3 WASHC5 HYDIN | 1.23e-04 | 280 | 45 | 10 | HP:0011563 |
| HumanPheno | Abnormal connection of the cardiac segments | HSPG2 CCDC22 BICRA ARID1A DACT1 VAC14 KMT2D GPC3 WASHC5 HYDIN | 1.38e-04 | 284 | 45 | 10 | HP:0011545 |
| HumanPheno | Dilatation of the renal pelvis | HSPG2 CCDC22 USP9X POLE ITGB4 POLR3A RAB3GAP1 KMT2D GPC3 WASHC5 | 1.65e-04 | 290 | 45 | 10 | HP:0010946 |
| HumanPheno | Tetralogy of Fallot | 1.77e-04 | 185 | 45 | 8 | HP:0001636 | |
| HumanPheno | Dandy-Walker malformation | 2.02e-04 | 141 | 45 | 7 | HP:0001305 | |
| HumanPheno | Abnormal renal pelvis morphology | HSPG2 CCDC22 USP9X POLE ITGB4 POLR3A RAB3GAP1 KMT2D GPC3 WASHC5 | 2.18e-04 | 300 | 45 | 10 | HP:0010944 |
| HumanPheno | Hypotelorism | 2.50e-04 | 146 | 45 | 7 | HP:0000601 | |
| HumanPheno | Adrenal hypoplasia | 2.55e-04 | 36 | 45 | 4 | HP:0000835 | |
| HumanPheno | Giant somatosensory evoked potentials | 2.61e-04 | 147 | 45 | 7 | HP:0001312 | |
| HumanPheno | Abnormality of the scalp hair | HSPG2 MYH3 CCDC22 BICRA ARID1A ITGB4 POLR3A VAC14 RAB3GAP1 KMT2D WASHC5 DNA2 | 2.62e-04 | 433 | 45 | 12 | HP:0100037 |
| HumanPheno | Aplasia/Hypoplasia of the cerebellar vermis | CCDC22 USP9X NUP88 ARID1A POLR3A EPG5 RAB3GAP1 GPC3 SACS WASHC5 DYNC1H1 | 2.67e-04 | 369 | 45 | 11 | HP:0006817 |
| HumanPheno | Cerebellar vermis hypoplasia | CCDC22 USP9X NUP88 ARID1A POLR3A EPG5 RAB3GAP1 GPC3 SACS WASHC5 DYNC1H1 | 2.67e-04 | 369 | 45 | 11 | HP:0001320 |
| HumanPheno | Abnormal cerebellar vermis morphology | CCDC22 USP9X NUP88 ARID1A POLR3A EPG5 RAB3GAP1 GPC3 SACS WASHC5 DYNC1H1 | 3.00e-04 | 374 | 45 | 11 | HP:0002334 |
| HumanPheno | Abnormality of peripheral nervous system electrophysiology | MYH3 CCDC22 USP9X MATR3 NUP88 ARID1A POLR3A GPC3 SACS WASHC5 | 3.24e-04 | 315 | 45 | 10 | HP:0030177 |
| HumanPheno | Aplasia/Hypoplasia of the nails | 3.39e-04 | 258 | 45 | 9 | HP:0008386 | |
| HumanPheno | Abnormal peripheral nervous system physiology | MYH3 CCDC22 USP9X MATR3 NUP88 ARID1A POLR3A GPC3 SACS WASHC5 | 3.59e-04 | 319 | 45 | 10 | HP:0032120 |
| HumanPheno | Abnormal scalp morphology | HSPG2 MYH3 CCDC22 BICRA ARID1A ITGB4 POLR3A VAC14 RAB3GAP1 KMT2D WASHC5 DNA2 | 3.75e-04 | 450 | 45 | 12 | HP:0001965 |
| HumanPheno | Conotruncal defect | 4.02e-04 | 264 | 45 | 9 | HP:0001710 | |
| HumanPheno | Abnormal external genitalia | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 UPF3B ARID1A ITGB4 POLR3A EPG5 TFR2 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 SACS WASHC5 TLR4 LTBP1 TNXB | 4.56e-04 | 1372 | 45 | 23 | HP:0000811 |
| HumanPheno | Abnormality of somatosensory evoked potentials | 4.56e-04 | 161 | 45 | 7 | HP:0007377 | |
| HumanPheno | Low-set ears | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 U2AF2 UPF3B POLR3A EPG5 VAC14 RAB3GAP1 KMT2D WASHC5 UHRF1 | 4.82e-04 | 761 | 45 | 16 | HP:0000369 |
| HumanPheno | Abnormal fourth ventricle morphology | 5.29e-04 | 165 | 45 | 7 | HP:0010950 | |
| HumanPheno | Dilated fourth ventricle | 5.29e-04 | 165 | 45 | 7 | HP:0002198 | |
| HumanPheno | Cerebellar cyst | 5.49e-04 | 166 | 45 | 7 | HP:0002350 | |
| HumanPheno | Atrial septal defect | CCDC22 BICRA USP9X UPF3B ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 DNA2 | 5.58e-04 | 541 | 45 | 13 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | CCDC22 BICRA USP9X UPF3B ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 DNA2 | 5.58e-04 | 541 | 45 | 13 | HP:0001630 |
| HumanPheno | Abnormal cardiac atrium morphology | CCDC22 BICRA USP9X UPF3B ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 DNA2 HYDIN | 5.78e-04 | 617 | 45 | 14 | HP:0005120 |
| HumanPheno | Abnormal pinna morphology | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 U2AF2 UPF3B ARID1A ITGB4 POLR3A EPG5 TGM1 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 DNA2 | 5.85e-04 | 1299 | 45 | 22 | HP:0000377 |
| HumanPheno | Abnormal atrial septum morphology | CCDC22 BICRA USP9X UPF3B ARID1A POLR3A EPG5 DACT1 VAC14 KMT2D GPC3 WASHC5 DNA2 | 5.89e-04 | 544 | 45 | 13 | HP:0011994 |
| HumanPheno | Abnormal nasal bridge morphology | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 POLRMT U2AF2 UPF3B ARID1A POLR3A EPG5 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 LTBP1 | 6.05e-04 | 1029 | 45 | 19 | HP:0000422 |
| HumanPheno | Preauricular skin tag | 6.66e-04 | 81 | 45 | 5 | HP:0000384 | |
| HumanPheno | Periauricular skin tag | 6.66e-04 | 81 | 45 | 5 | HP:0100278 | |
| HumanPheno | Pursed lips | 7.50e-04 | 5 | 45 | 2 | HP:0000205 | |
| HumanPheno | Pterygium | 7.79e-04 | 48 | 45 | 4 | HP:0001059 | |
| HumanPheno | High palate | HSPG2 MYH3 CCDC22 BICRA USP9X NUP88 POLRMT UPF3B ARID1A EPG5 VAC14 RAB3GAP1 KMT2D GPC3 WASHC5 LTBP1 | 7.81e-04 | 794 | 45 | 16 | HP:0000218 |
| HumanPheno | Abnormal male external genitalia morphology | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 UPF3B ARID1A ITGB4 POLR3A EPG5 TFR2 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 SACS WASHC5 TLR4 LTBP1 | 8.21e-04 | 1329 | 45 | 22 | HP:0000032 |
| HumanPheno | Unsteady gait | CCDC22 USP9X MATR3 NUP88 ARID1A POLR3A VAC14 GPC3 SACS WASHC5 | 8.76e-04 | 357 | 45 | 10 | HP:0002317 |
| HumanPheno | Retinal coloboma | 8.76e-04 | 86 | 45 | 5 | HP:0000480 | |
| HumanPheno | Abnormality of the outer ear | HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 U2AF2 UPF3B ARID1A ITGB4 POLR3A EPG5 TGM1 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 DNA2 | 8.96e-04 | 1337 | 45 | 22 | HP:0000356 |
| HumanPheno | Abnormality of the male genitalia | EPHB2 HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 UPF3B ARID1A ITGB4 POLR3A EPG5 TFR2 DACT1 VAC14 RAB3GAP1 KMT2D GPC3 SACS WASHC5 TLR4 LTBP1 | 9.32e-04 | 1437 | 45 | 23 | HP:0010461 |
| HumanPheno | Abnormality of skeletal muscles | HSPG2 MYH3 MATR3 NUP88 POLRMT ARID1A POLR3A KY GPC3 SACS WASHC5 UHRF1 DNA2 TNXB DYNC1H1 | 9.54e-04 | 727 | 45 | 15 | HP:0040290 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | RAG1 HSPG2 MYH3 CCDC22 BICRA USP9X POLE NUP88 UPF3B ARID1A POLR3A EPG5 KY DACT1 VAC14 RAB3GAP1 KMT2D GPC3 WASHC5 UHRF1 DNA2 DYNC1H1 | 9.57e-04 | 1343 | 45 | 22 | HP:0009115 |
| HumanPheno | Abnormal toe morphology | RAG1 HSPG2 MYH3 CCDC22 USP9X NUP88 UPF3B ARID1A ITGB4 POLR3A DACT1 VAC14 RAB3GAP1 KMT2D GPC3 SACS DNA2 | 9.69e-04 | 893 | 45 | 17 | HP:0001780 |
| HumanPheno | Congenital malformation of the left heart | 9.81e-04 | 51 | 45 | 4 | HP:0045017 | |
| HumanPheno | Small nail | 9.82e-04 | 183 | 45 | 7 | HP:0001792 | |
| HumanPheno | Flexion contracture of finger | 1.02e-03 | 240 | 45 | 8 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 1.02e-03 | 240 | 45 | 8 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 1.02e-03 | 240 | 45 | 8 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 1.02e-03 | 240 | 45 | 8 | HP:0100490 | |
| HumanPheno | Interphalangeal joint contracture of finger | 1.02e-03 | 240 | 45 | 8 | HP:0001220 | |
| HumanPheno | Camptodactyly of toe | 1.02e-03 | 240 | 45 | 8 | HP:0001836 | |
| HumanPheno | Flexion contracture of toe | 1.02e-03 | 240 | 45 | 8 | HP:0005830 | |
| HumanPheno | Abnormal localization of kidney | 1.05e-03 | 241 | 45 | 8 | HP:0100542 | |
| HumanPheno | Toe joint contracture | 1.05e-03 | 241 | 45 | 8 | HP:0034675 | |
| HumanPheno | Myalgia | 1.12e-03 | 187 | 45 | 7 | HP:0003326 | |
| HumanPheno | Abnormal finger phalanx morphology | HSPG2 MYH3 CCDC22 BICRA USP9X NUP88 UPF3B ARID1A POLR3A DACT1 VAC14 RAB3GAP1 KMT2D GPC3 WASHC5 | 1.12e-03 | 738 | 45 | 15 | HP:0005918 |
| HumanPheno | Recurrent respiratory infections | RAG1 MYH3 CCDC22 USP9X POLE ARID1A POLR3A EPG5 TGM1 KMT2D WASHC5 UHRF1 LTBP1 HYDIN | 1.14e-03 | 660 | 45 | 14 | HP:0002205 |
| HumanPheno | Abnormality of muscle size | HSPG2 MYH3 MATR3 NUP88 POLRMT ARID1A POLR3A KY GPC3 SACS WASHC5 UHRF1 DNA2 TNXB DYNC1H1 | 1.15e-03 | 740 | 45 | 15 | HP:0030236 |
| HumanPheno | Ectopic kidney | 1.25e-03 | 93 | 45 | 5 | HP:0000086 | |
| HumanPheno | Aplasia/Hypoplasia of the ribs | 1.30e-03 | 140 | 45 | 6 | HP:0006712 | |
| HumanPheno | Enlarged posterior fossa | 1.34e-03 | 193 | 45 | 7 | HP:0005445 | |
| Domain | Ceramidse_alk_C | 4.88e-05 | 2 | 131 | 2 | PF17048 | |
| Domain | NEUT/ALK_ceramidase_C | 4.88e-05 | 2 | 131 | 2 | IPR031331 | |
| Domain | Ceramidase_alk | 4.88e-05 | 2 | 131 | 2 | IPR006823 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CCDC22 POLE MATR3 DLGAP5 RPP38 POLRMT U2AF2 CHD1L ARID1A SLC1A5 POLR3A DECR1 TGM1 RAB3GAP1 CYFIP1 BAZ2A WASHC5 IQSEC1 DDX43 TIMM44 DYNC1H1 GNL3 | 9.77e-09 | 1353 | 133 | 22 | 29467282 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | POLE NUP88 POLRMT U2AF2 POLR3A DPH6 IGF2BP1 RAB3GAP1 IGF2BP3 CYFIP1 TIMM44 DYNC1H1 RSL24D1 ILKAP | 5.69e-07 | 704 | 133 | 14 | 29955894 |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 33436560 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYL4 MATR3 U2AF2 CHD1L SLC1A5 DECR1 MRPL39 IGF2BP1 IGF2BP3 BAZ2A WASHC5 TNRC6A IQSEC1 DDX43 TIMM44 DYNC1H1 GNL3 RSL24D1 | 2.98e-06 | 1318 | 133 | 18 | 30463901 |
| Pubmed | 8.12e-06 | 347 | 133 | 9 | 16033648 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.06e-05 | 272 | 133 | 8 | 25315684 | |
| Pubmed | 1.45e-05 | 80 | 133 | 5 | 35803934 | ||
| Pubmed | Genomic structure and promoter analysis of the mouse neutral ceramidase gene. | 1.45e-05 | 2 | 133 | 2 | 12435403 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11328816 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28236635 | ||
| Pubmed | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | 1.45e-05 | 2 | 133 | 2 | 19345744 | |
| Pubmed | Lactosylceramide contributes to mitochondrial dysfunction in diabetes. | 1.45e-05 | 2 | 133 | 2 | 26900161 | |
| Pubmed | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. | 1.45e-05 | 2 | 133 | 2 | 17334805 | |
| Pubmed | Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. | 1.45e-05 | 2 | 133 | 2 | 26747710 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17574766 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15059886 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10753931 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 36130690 | ||
| Pubmed | ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. | 1.45e-05 | 2 | 133 | 2 | 38754421 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16380386 | ||
| Pubmed | Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. | 1.45e-05 | 2 | 133 | 2 | 22826216 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31971710 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12921532 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11992722 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10652340 | ||
| Pubmed | Neutral ceramidase gene: role in regulating ceramide-induced apoptosis. | 1.45e-05 | 2 | 133 | 2 | 14557071 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 35354041 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16126722 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25701119 | ||
| Pubmed | Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. | 1.45e-05 | 2 | 133 | 2 | 22940715 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24659784 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21613224 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12719380 | ||
| Pubmed | Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. | 1.45e-05 | 2 | 133 | 2 | 35151662 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25945837 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 37944753 | ||
| Pubmed | TLR4 and RAGE: similar routes leading to inflammation in type 2 diabetic patients. | 1.45e-05 | 2 | 133 | 2 | 21377387 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 27609772 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 1.45e-05 | 2 | 133 | 2 | 16541107 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | THNSL1 POLE MATR3 POLRMT U2AF2 DGKE ZDBF2 UPF3B POLR3A DECR1 MRPL39 IGF2BP1 RAB3GAP1 IGF2BP3 BAZ2A ESPL1 TIMM44 GNL3 | 1.67e-05 | 1496 | 133 | 18 | 32877691 |
| Pubmed | 2.18e-05 | 87 | 133 | 5 | 33711283 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 MGAT4B BICRA POLE POLRMT PER1 ARID1A ITGB4 SLC1A5 NHSL1 DACT1 VAC14 KMT2D ESPL1 DYNC1H1 | 2.27e-05 | 1105 | 133 | 15 | 35748872 |
| Pubmed | IL16 BICRA RPP38 POLRMT PER1 U2AF2 DGKE ZKSCAN2 ARID1A INO80D BAZ2A TNRC6A IQSEC1 DNA2 GNL3 | 2.55e-05 | 1116 | 133 | 15 | 31753913 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 2.71e-05 | 91 | 133 | 5 | 34445801 | |
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 4.34e-05 | 3 | 133 | 2 | 17296566 | |
| Pubmed | The molecular circuitry regulating the switch between iron deficiency and overload in mice. | 4.34e-05 | 3 | 133 | 2 | 16418170 | |
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 4.34e-05 | 3 | 133 | 2 | 29476152 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 20803549 | ||
| Pubmed | Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1. | 4.34e-05 | 3 | 133 | 2 | 12921776 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 27387124 | ||
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 4.34e-05 | 3 | 133 | 2 | 32668274 | |
| Pubmed | Microtubule-bundling protein Spef1 enables mammalian ciliary central apparatus formation. | 4.34e-05 | 3 | 133 | 2 | 30535028 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 20627640 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 38302493 | ||
| Pubmed | Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation. | 4.34e-05 | 3 | 133 | 2 | 34613626 | |
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 4.34e-05 | 3 | 133 | 2 | 16049158 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9891060 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19349620 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22156594 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18955860 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 32134323 | ||
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 4.34e-05 | 3 | 133 | 2 | 15601260 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31375667 | ||
| Pubmed | TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4. | 4.34e-05 | 3 | 133 | 2 | 37221403 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 24825601 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 20080952 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31515281 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 30832689 | ||
| Pubmed | USP9X IGF2BP1 RAB3GAP1 IGF2BP3 GPC3 WASHC5 ABRAXAS1 UHRF1 ESPL1 | 4.54e-05 | 432 | 133 | 9 | 7671812 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | USP9X PRR5 PER1 U2AF2 ARID1A SLC1A5 ANKRD44 RAB3GAP1 ABRAXAS1 EIF2AK1 DYNC1H1 | 5.64e-05 | 670 | 133 | 11 | 22990118 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | USP9X MATR3 PRR5 POLRMT U2AF2 UPF3B MRPL39 IGF2BP1 IGF2BP3 IQSEC1 GNL3 | 6.27e-05 | 678 | 133 | 11 | 30209976 |
| Pubmed | MATR3 RPP38 U2AF2 CHD1L UPF3B SLC1A5 DECR1 IGF2BP1 IGF2BP3 GPC3 TNRC6A IQSEC1 UHRF1 TIMM44 DYNC1H1 GNL3 | 7.30e-05 | 1371 | 133 | 16 | 36244648 | |
| Pubmed | 8.50e-05 | 469 | 133 | 9 | 27634302 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 34645806 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 20404100 | ||
| Pubmed | H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. | 8.67e-05 | 4 | 133 | 2 | 10875929 | |
| Pubmed | mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. | 8.67e-05 | 4 | 133 | 2 | 21576258 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 15225648 | ||
| Pubmed | Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. | 8.67e-05 | 4 | 133 | 2 | 26690704 | |
| Pubmed | Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. | 8.67e-05 | 4 | 133 | 2 | 33547170 | |
| Pubmed | Regulation of transferrin receptor 2 protein levels by transferrin. | 8.67e-05 | 4 | 133 | 2 | 15319276 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 26160756 | ||
| Pubmed | IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories. | 8.67e-05 | 4 | 133 | 2 | 27385015 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 29038008 | ||
| Pubmed | Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer. | 8.67e-05 | 4 | 133 | 2 | 29136504 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 21737611 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 27184842 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 26138514 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 32745117 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 12962157 | ||
| Pubmed | Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells. | 8.67e-05 | 4 | 133 | 2 | 11591392 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NRDC USP9X POLE MATR3 NUP88 POLRMT U2AF2 UPF3B SLC1A5 POLR3A IGF2BP1 CYFIP1 UHRF1 TIMM44 DYNC1H1 GNL3 | 1.14e-04 | 1425 | 133 | 16 | 30948266 |
| Pubmed | HSPG2 BICRA USP9X MATR3 NUP88 RAD54L2 ARID1A INO80D SLC1A5 MRPL39 IGF2BP1 IGF2BP3 KMT2D TNRC6A DYNC1H1 GNL3 | 1.18e-04 | 1429 | 133 | 16 | 35140242 | |
| Pubmed | EPHB6 USP9X ADAM30 DGKE ARID1A POLR3A DMXL1 SGK3 TGM1 PLCB2 GNL3 | 1.20e-04 | 730 | 133 | 11 | 34857952 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 1.44e-04 | 5 | 133 | 2 | 2277065 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 19324964 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 16208538 | ||
| Pubmed | Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. | 1.44e-04 | 5 | 133 | 2 | 22034510 | |
| Pubmed | Allergen endotoxins induce T-cell-dependent and non-IgE-mediated nasal hypersensitivity in mice. | 1.44e-04 | 5 | 133 | 2 | 27287257 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 16807365 | ||
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.27e-05 | 258 | 131 | 9 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ADAD1 THNSL1 USP9X POLE NUP88 CHD1L USP37 DMXL1 TDRD7 BAZ2A ABRAXAS1 USP32 ANKRD12 DDX43 DNA2 ESPL1 | 4.63e-05 | 820 | 131 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | EPHB2 RAG1 MYL4 POLE DLGAP5 IGF2BP1 IGF2BP3 UHRF1 DNA2 ESPL1 GNL3 | 5.90e-05 | 419 | 131 | 11 | GSM538348_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | EPHB2 RAG1 MYL4 POLE DLGAP5 IGF2BP1 IGF2BP3 UHRF1 DNA2 ESPL1 GNL3 | 6.29e-05 | 422 | 131 | 11 | GSM538357_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | EPHB2 RAG1 MYL4 POLE DLGAP5 IGF2BP1 IGF2BP3 UHRF1 DNA2 ESPL1 GNL3 | 6.29e-05 | 422 | 131 | 11 | GSM538355_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | THNSL1 POLE DLGAP5 RPP38 NUP88 CHD1L VAC14 IGF2BP1 BAZ2A DDX43 DNA2 ESPL1 GNL3 RSL24D1 PRIMPOL | 9.68e-05 | 781 | 131 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | THNSL1 POLE DLGAP5 RPP38 NUP88 CHD1L VAC14 IGF2BP1 BAZ2A DDX43 DNA2 ESPL1 GNL3 RSL24D1 PRIMPOL | 1.24e-04 | 799 | 131 | 15 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ADAD1 THNSL1 POLE RPP38 NUP88 CHD1L SGK3 TDRD7 BAZ2A ABRAXAS1 ANKRD12 DDX43 DNA2 ESPL1 GNL3 | 1.45e-04 | 810 | 131 | 15 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | 1.63e-04 | 83 | 131 | 5 | GSM791134_100 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 198 | 133 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-07 | 165 | 133 | 7 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 186 | 133 | 7 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 186 | 133 | 7 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 186 | 133 | 7 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 193 | 133 | 7 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-06 | 198 | 133 | 7 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-06 | 155 | 133 | 6 | a16e3a72badafa78a3efc4f4ab62396f0ce99d1e | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-05 | 164 | 133 | 6 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-05 | 164 | 133 | 6 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 166 | 133 | 6 | d80c2522cf314d56730d60f160b1247933443378 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 166 | 133 | 6 | f2593e2f1043a8cedaa677a73e6b28393991b910 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 167 | 133 | 6 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-05 | 168 | 133 | 6 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 171 | 133 | 6 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 171 | 133 | 6 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 171 | 133 | 6 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 171 | 133 | 6 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.50e-05 | 176 | 133 | 6 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | severe-multiplets|World / disease stage, cell group and cell class | 1.81e-05 | 182 | 133 | 6 | 5e30ec7120a988d9ee3000513e1209618f28f5f9 | |
| ToppCell | severe-multiplets|severe / disease stage, cell group and cell class | 1.86e-05 | 183 | 133 | 6 | 78af8df48f0fe49ac37ccec0ad7b2993883b1148 | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 1.86e-05 | 183 | 133 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | MS-IIF-Others-RBC|IIF / Disease, condition lineage and cell class | 1.92e-05 | 184 | 133 | 6 | 578bde79b464ed12dd9a53dd8e2839e156220a60 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-05 | 186 | 133 | 6 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_reticulocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.04e-05 | 186 | 133 | 6 | bf8ca7135c05d772aa3f5960b419a13aef3936ae | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.17e-05 | 188 | 133 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 2.24e-05 | 189 | 133 | 6 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 2.30e-05 | 190 | 133 | 6 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 191 | 133 | 6 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 192 | 133 | 6 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 192 | 133 | 6 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.52e-05 | 193 | 133 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 193 | 133 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-05 | 193 | 133 | 6 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | Megakaryocytic-erythropoietic|World / Lineage, cell class and subclass | 2.52e-05 | 193 | 133 | 6 | 805c2e2e5d8a9df5ce796d5c0206d6493ab53c88 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 2.59e-05 | 194 | 133 | 6 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-05 | 194 | 133 | 6 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Unfolded_protein_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-05 | 195 | 133 | 6 | 9873de83b67e9645112897d3391c2d9afaa9970e | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.67e-05 | 195 | 133 | 6 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.67e-05 | 195 | 133 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-05 | 195 | 133 | 6 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-05 | 196 | 133 | 6 | 0aae78e73d53416d857bdf21f595a0a0a0ba7944 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-05 | 197 | 133 | 6 | d8f99a9f2367c8bc9308b0c64d0226875262927a | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 2.82e-05 | 197 | 133 | 6 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.82e-05 | 197 | 133 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 197 | 133 | 6 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.82e-05 | 197 | 133 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 197 | 133 | 6 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 198 | 133 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 199 | 133 | 6 | 8d0eb13a391a2ac1b4f332290c2d00a7fb42bddc | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 199 | 133 | 6 | c555d88b66939e7dff2cb44d1f8feb53fbd8bd82 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 199 | 133 | 6 | e6853b2c0ef6549d5554754c5d5f65825b66025b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Influenza-Influenza_Severe-Others|Influenza_Severe / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | 8909da4f7da3bc469a2becb4cfa5c25012af5845 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 200 | 133 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|erythropoietic / Lineage and Cell class | 3.07e-05 | 200 | 133 | 6 | 27056f28328df2a51d5634a7927b7084241e3ca2 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Ionocyte-iono-4|World / Class top | 4.29e-05 | 129 | 133 | 5 | 85ee6e16959cb58a58f5b09edf1f78d9ce6a9441 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 132 | 133 | 5 | a1f98d9245c8fe02ea3f098f04919a7d5fc6cbc7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 134 | 133 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-05 | 138 | 133 | 5 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-05 | 139 | 133 | 5 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-05 | 139 | 133 | 5 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.25e-05 | 144 | 133 | 5 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.25e-05 | 148 | 133 | 5 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 8.51e-05 | 149 | 133 | 5 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-05 | 152 | 133 | 5 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 9.94e-05 | 154 | 133 | 5 | 423f58fc7dcef068458cbf7b4ee989e37227041e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 155 | 133 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 155 | 133 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 156 | 133 | 5 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 159 | 133 | 5 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 159 | 133 | 5 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 160 | 133 | 5 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.26e-04 | 162 | 133 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 163 | 133 | 5 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 164 | 133 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 164 | 133 | 5 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 164 | 133 | 5 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 165 | 133 | 5 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 169 | 133 | 5 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 169 | 133 | 5 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 170 | 133 | 5 | 2491f3849e34b0ccd06015fa59d15e3d7963c76d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 171 | 133 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 171 | 133 | 5 | 1176577841bb6cff27ca288e0c89d2e2242efbb3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 171 | 133 | 5 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 171 | 133 | 5 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 171 | 133 | 5 | a350a5f840e0fb0ccd29bb29cacc23a89abd8404 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 171 | 133 | 5 | e0a99ca8d4c86b58f54af7755ffd8e0ffbfae5e1 | |
| Disease | 3C syndrome | 1.90e-05 | 2 | 129 | 2 | C0796137 | |
| Disease | tenascin-X measurement | 1.13e-04 | 4 | 129 | 2 | EFO_0802121 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 1.13e-04 | 4 | 129 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CHL1 EPHB6 EFS POLE PER1 SPNS3 ARID1A DACT1 IGFBP3 SACS TLR4 | 2.68e-04 | 702 | 129 | 11 | C0009402 |
| Disease | 10-undecenoate 11:1n1 measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0021099 | |
| Disease | Myofibrillar Myopathy | 5.22e-04 | 8 | 129 | 2 | C2678065 | |
| Disease | Carcinoma, Transitional Cell | 7.71e-04 | 41 | 129 | 3 | C0007138 | |
| Disease | ankylosing spondylitis (is_marker_for) | 8.34e-04 | 10 | 129 | 2 | DOID:7147 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 9.89e-04 | 100 | 129 | 4 | C0010606 | |
| Disease | X-12063 measurement | 1.38e-03 | 186 | 129 | 5 | EFO_0021283 | |
| Disease | Adenocarcinoma Of Esophagus | 1.67e-03 | 14 | 129 | 2 | C0279628 | |
| Disease | Proteinuria | 1.92e-03 | 15 | 129 | 2 | HP_0000093 | |
| Disease | T-Cell Lymphoma | 2.19e-03 | 16 | 129 | 2 | C0079772 | |
| Disease | Bladder Neoplasm | 3.38e-03 | 140 | 129 | 4 | C0005695 | |
| Disease | number of teeth measurement | 3.42e-03 | 20 | 129 | 2 | EFO_0010073 | |
| Disease | Malignant neoplasm of urinary bladder | 3.47e-03 | 141 | 129 | 4 | C0005684 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.76e-03 | 71 | 129 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Arthrogryposis | 3.77e-03 | 21 | 129 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQKGLFHRVPLVVAN | 156 | Q6UWZ7 | |
| HRQIVKPGFNISILK | 136 | Q8N1L4 | |
| GRRFFQSPAHINLLK | 1336 | Q9HCE0 | |
| GQLFPHRARIEIKNK | 326 | A6H8Y1 | |
| ENNGVAKHISRFILP | 366 | Q15758 | |
| QPPQQKAAVLAFLVH | 966 | Q9UIF9 | |
| FGHNRKQDILKPAVI | 136 | P0C7U1 | |
| IAAGHQIVALANLRP | 21 | Q7L8W6 | |
| LGVFVRHNATPVVKA | 586 | Q14416 | |
| IILFQPQKNVVSHRA | 816 | Q14416 | |
| GVALDPKNNLVIFHR | 516 | P19021 | |
| KRGEINPVSALHQFA | 91 | Q96M93 | |
| VNIRAIINHFNPKIE | 591 | Q5T2E6 | |
| KPIRLLANHFQVQIP | 26 | Q9HCK5 | |
| AKLGGINNVLVPHQR | 561 | Q9HCK5 | |
| VFLAPQLARAVKPHQ | 261 | Q9Y4B4 | |
| IVKLLLRHGGNPFQA | 266 | Q6UB98 | |
| QGSALQKPFHASRLV | 156 | O60826 | |
| DRLQQRLPITQHFGK | 491 | Q8IV53 | |
| RLQIIPGAKHGNIQV | 46 | Q9Y485 | |
| VKAITGRQIFQPLHA | 491 | P15918 | |
| GRIIHKLFVNAQRAA | 891 | Q15042 | |
| RQGKVKAFAHLQVPE | 3646 | P98160 | |
| PLGKASFHIPQVQVR | 81 | Q9BQ51 | |
| AGILAQHAQPVNEKR | 711 | Q86VS3 | |
| IFNAVIKEHPGLVQR | 296 | Q8N3Y3 | |
| QKADIHLVPVLRGQA | 771 | Q9NPG4 | |
| FGISPAQSHRNIKIL | 1941 | O14497 | |
| APFQNILPRVHVKEG | 1026 | Q7L576 | |
| LVNLTAHLRQKAGLP | 21 | Q8WYQ4 | |
| ARLFGALQHPNIIAL | 146 | Q02779 | |
| PFGVISNHLILNKIN | 421 | P43243 | |
| HPKEVNILRFSGQRN | 861 | O00533 | |
| NLRIRFKPSLFQHVG | 356 | Q9UQ53 | |
| HQVRSFFQRLQPGLK | 36 | P51654 | |
| EVPLKILAHNNFVGR | 276 | Q9NZI8 | |
| ANRNVPFKLKLHGIA | 591 | Q8NBH2 | |
| FGHNRKQDILKPAVI | 751 | Q9NR71 | |
| NKPQKLGLHQREIFL | 766 | Q6DN90 | |
| TAGHQQPFLELKIRA | 211 | P58166 | |
| PRHSVINVFVGRAQK | 636 | Q5SYE7 | |
| DRNHRPKFGQIVNTL | 866 | P29323 | |
| QRPVVFLQHGLLASA | 76 | P07098 | |
| LAIHKKILQLAGQPF | 406 | O15534 | |
| APFQLSNHTGRIKVV | 341 | Q14766 | |
| IHRFGKQAPHLVQVV | 266 | Q8NGK0 | |
| NKVITVHRVFPNGLA | 1136 | Q14005 | |
| TRIRPELVKNGQFHI | 71 | Q8N423 | |
| LLKQIGVFSPSLRNH | 546 | Q8N3J3 | |
| FLPILQHISRNKEQG | 116 | P12829 | |
| RNGIFHRDVKPENIL | 121 | Q9UQ07 | |
| ALQTPLHVAARNGLK | 941 | Q8N8A2 | |
| HKALFGIFIPSQRRA | 1496 | Q07864 | |
| IHQFILEQQKGNRVP | 481 | Q9UBE8 | |
| VRRFHVQLSNPKFGA | 1076 | P16144 | |
| NLKVPANDFIGHRIV | 136 | A6NFQ7 | |
| EIPLKILAHNNFVGR | 276 | O00425 | |
| VAHNKLSVAPQFLPR | 131 | Q6PEZ8 | |
| PKIKVHRFLLQAVNQ | 266 | Q9BZI7 | |
| LIKVAGHPNIVINNA | 131 | Q16698 | |
| VFFRQVIGNHLKPKQ | 706 | Q9UKF2 | |
| VLQSGLKFVAARIPH | 1246 | Q14674 | |
| LLVRNIGNKNAVFHI | 221 | Q4G0P3 | |
| ILHFGVLPLANAKLQ | 431 | Q8NFQ6 | |
| KAQFIPGQQPSVRLH | 556 | Q9NYF0 | |
| RNIFLHGPDQQVKIG | 446 | Q9BQI3 | |
| RQLTLHKGVQIPAFG | 41 | Q6ZN84 | |
| RKTLGDLIPRHQQVF | 216 | Q00532 | |
| HVLFPLNLQLGAKVD | 361 | Q2VPA4 | |
| ERHLAIKNFGQQPIF | 401 | Q86WJ1 | |
| NLHQNLIRKFPKGDV | 166 | Q9H0C8 | |
| RNRHFGLKDVNIPTL | 41 | Q15398 | |
| LHGQQGIVPANRVKL | 51 | O43281 | |
| QHRVIGKLIQCLFGP | 181 | Q9ULV5 | |
| AALLHAIARRPKGQQ | 856 | Q6P179 | |
| NSHLQVLGFIPKKER | 76 | Q53TQ3 | |
| LGFRVPLAIVNKAHQ | 756 | Q14204 | |
| VKALGHQLGRFVLVF | 1916 | Q14204 | |
| RAIKGPHLANSILFQ | 441 | Q9BVP2 | |
| HFKPIVLAQNASVAR | 676 | Q76NI1 | |
| IQVKLANPFRIGQAH | 491 | P52429 | |
| ERFHQVPSGIILQNK | 961 | Q9NZM4 | |
| FLRLGQIQKVHPAIQ | 696 | P51530 | |
| GRFILDNLKPHLVAA | 706 | Q9NZJ4 | |
| RNVLLKNVKHPFLVG | 211 | Q96BR1 | |
| SFRNVQQIGILKPHP | 611 | O00411 | |
| FIHLVLQPSLKGQRN | 301 | Q9NXZ2 | |
| DNIHVGNFLRKILQP | 181 | Q96LW4 | |
| LNHLKFLNVLSPRGV | 221 | P17936 | |
| QLIPDQLRHLGNAIK | 666 | Q99567 | |
| ALNVQIIAALIKPFG | 246 | Q93008 | |
| VKVARGAVLPHFNVL | 121 | Q08AM6 | |
| QNPERIVKLHRIGDF | 246 | Q9NYK5 | |
| FINKIAGHPLAQNER | 126 | Q9UMY4 | |
| VLRAVGKHSPQLAQA | 106 | O75602 | |
| PAHVRKQLAIGVNEV | 106 | P78345 | |
| IHNGVIAVFQRKGLP | 46 | P85299 | |
| FQHPNILRLEGVVTK | 726 | O15197 | |
| INFLRKLVQNGPEVH | 401 | O14802 | |
| QQLDTKLPRQHFIGV | 446 | P11055 | |
| LRAVLQSHKNGVALP | 11 | Q8NHU6 | |
| KHVRQNIGPVAAFRN | 621 | Q9H6R3 | |
| HDAIKLFIGQIPRNL | 51 | Q9BZC1 | |
| ADGFIHRIVPKLIQN | 11 | Q6UVW9 | |
| HRQIVKPGFNISILK | 136 | Q86W10 | |
| KLVVHIRGKQPAVFN | 141 | Q17RW2 | |
| ILQDGFPIRIKAVHV | 211 | Q9BTX7 | |
| VGFAALPNQLHRKSV | 11 | Q8WYJ6 | |
| KRVAFALHRGLIFNP | 716 | Q12768 | |
| LFRSGVQTLPHNAKV | 471 | Q8IUR5 | |
| HRRGFAQVAIDAKVP | 216 | Q96MH6 | |
| VQALIDKHQRIPGNI | 301 | Q96MH6 | |
| APNAIKIEFAQRIGH | 351 | Q8NB66 | |
| APKFLLEARVVHGLQ | 281 | Q6ZMD2 | |
| KRGAFHLAVQAQVPI | 191 | Q99943 | |
| HEAFNRLLGDPVVQK | 106 | A6NLX3 | |
| GGEKQVVFTHRINLP | 66 | P22105 | |
| QQPLEFVHKIGASVR | 146 | Q9HCK1 | |
| EVKQNIHLIRAPLAG | 126 | Q9UHA3 | |
| IRVKGFNHKLPLLFQ | 761 | O43847 | |
| KIAPVRHLSGNQFIL | 326 | Q8IYQ7 | |
| KFLGHRIIPINALNS | 761 | Q00722 | |
| LAHPIQQAKALGLQF | 351 | O43615 | |
| KIQELFHVEPGLQRL | 31 | Q96T88 | |
| GIPRIFQLSHNIKNV | 46 | Q86T82 | |
| GIIFQGQSLKIRRPH | 216 | P26368 | |
| RKSEIHGAPVLFQNL | 481 | Q63HK3 | |
| NLRVHTSPNAIIGKF | 206 | P22735 | |
| IIPNNIRHKFGSNVV | 141 | O43247 | |
| QNSVHFELKPGVRVL | 1066 | Q8WY21 | |
| NFIQPGAFKEIRLHK | 216 | O00206 | |
| GEAFIRKPQLIKHQI | 371 | Q86T29 | |
| NLHKVLQGRLPAVAQ | 606 | Q9UP52 | |
| KQLLKRGQHFPVIAA | 146 | Q8NDV7 | |
| PILIIHLKRFQFVNG | 1276 | Q8NFA0 | |
| VHIQGQPFRAHKAVL | 36 | Q8NCN2 | |
| YNINLGKHLLPLVVQ | 1351 | Q9P2D8 | |
| QFIELRHNVQKGLGP | 2876 | O14686 |